Peptone

Peptone is a biotechnology and therapeutics company based in London, focused on developing novel small-molecule drugs that target intrinsically disordered proteins (IDPs).

Founded in 2018 by Dr. Kamil Tamiola and Dr. Matt Heberling, the company aims to unlock the therapeutic potential of IDPs, which are involved in various health conditions, including cancer and inflammatory diseases. Peptone employs a proprietary experimental physics product engine that integrates experimental biophysics, supercomputing, machine learning, and a specialized protein engineering operating system. This approach allows for advanced molecular analysis and drug discovery, enabling the design of lab-quality molecules efficiently. The company also operates a research and development facility in Bellinzona, Switzerland, dedicated to studying IDPs at scale. Peptone primarily serves the biopharmaceutical and healthcare industries, acting as a partner in drug discovery and translational biophysics.